Your browser doesn't support javascript.
loading
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
Wen, Ti; Barham, Whitney; Li, Ying; Zhang, Henan; Gicobi, Joanina K; Hirdler, Jacob B; Liu, Xin; Ham, Hyoungjun; Peterson Martinez, Kodi E; Lucien, Fabrice; Lavoie, Roxane R; Li, Hu; Correia, Cristina; Monie, Dileep D; An, Zesheng; Harrington, Susan M; Wu, Xiaosheng; Guo, Ruifeng; Dronca, Roxana S; Mansfield, Aaron S; Yan, Yiyi; Markovic, Svetomir N; Park, Sean S; Sun, Jie; Qin, Hong; Liu, Minetta C; Vasmatzis, George; Billadeau, Daniel D; Dong, Haidong.
Afiliación
  • Wen T; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Barham W; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Li Y; Division of Computational Biology, Mayo Clinic, Rochester, Minnesota.
  • Zhang H; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Gicobi JK; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Hirdler JB; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Liu X; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Ham H; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Peterson Martinez KE; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Lucien F; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Lavoie RR; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Li H; Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Correia C; Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Monie DD; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • An Z; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Harrington SM; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Wu X; Division of Hematology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Guo R; Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.
  • Dronca RS; Division of Medical Oncology, Mayo Clinic, Jacksonville, Florida.
  • Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Yan Y; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Markovic SN; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Park SS; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
  • Sun J; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
  • Qin H; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
  • Liu MC; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida.
  • Vasmatzis G; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Billadeau DD; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Dong H; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Cancer Immunol Res ; 10(2): 162-181, 2022 02.
Article en En | MEDLINE | ID: mdl-34911739
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN Mensajero / Linfocitos T CD8-positivos / Inmunoterapia / Proteínas de la Membrana / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN Mensajero / Linfocitos T CD8-positivos / Inmunoterapia / Proteínas de la Membrana / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Año: 2022 Tipo del documento: Article